OC9:F:F-Omnicell Inc (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 40.6

Change

0.00 (0.00)%

Market Cap

USD 1.85B

Volume

10.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

+1.53 (+1.93%)

USD 35.91B
2HE:F Healthequity Inc

-1.00 (-1.42%)

USD 6.16B
4YC:F M3 INC.

+0.10 (+1.15%)

USD 5.81B
6HL0:F R1 RCM Inc

+0.10 (+0.79%)

USD 5.45B
9EH:F Evolent Health Inc

+0.40 (+1.46%)

USD 3.16B
1KJ:F 10X GENOMICS DL -00001

+2.23 (+11.83%)

USD 2.31B
6JM:F JMDC INC.

N/A

USD 1.93B
19P:F Phreesia Inc

-0.20 (-0.92%)

USD 1.26B
4LL:F Teladoc Inc

+0.05 (+0.60%)

USD 1.25B
1XZ:F Ping An Healthcare and Technol..

+0.02 (+1.57%)

USD 1.21B

ETFs Containing OC9:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.00% 73% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.00% 70% C- 68% D+
Trailing 12 Months  
Capital Gain -21.17% 56% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.17% 53% F 26% F
Trailing 5 Years  
Capital Gain -36.25% 45% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.25% 36% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain -1.78% 68% D+ 40% F
Dividend Return -1.78% 65% D 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 58.43% 11% F 17% F
Risk Adjusted Return -3.04% 67% D+ 39% F
Market Capitalization 1.85B 89% A- 66% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector